Lung cancer surgery: an up to date.

摘要: According to the International Agency for Research on Cancer (IARC) GLOBOCAN World Report, lung cancer affects more than 1 million people a year worldwide. In Greece according 2008 report, there were 6,667 cases recorded, 18% of total incidence all cancers in population. Furthermore, 6,402 deaths due cancer, 23.5% cancer. Therefore, our country, is most common and deadly form male The important prognostic indicator extent disease. Union Internationale Contre le (UICC) American Joint Committee Staging (AJCC) developed tumour, node, metastases (TNM) staging system which attempts define those patients who might be suitable radical surgery or radiotherapy, from majority, will only palliative measures. Surgery has an part therapy with “Lobectomy gold standard treatment”. This statement may challenged stage Ia limited pulmonary function. these anatomical segmentectomy lymph node dissection acceptable alternative. Chest wall invasion not contraindication resection. En-bloc rib resection reconstruction treatment choice. N2 disease represents both spectrum interface between surgical non-surgical Evidence trials suggests that multizone unresectable should treated primarily by chemoradiotherapy. There role if downstaged N0 lobectomy possible, but pneumonectomy avoidable. Small cell (SCLC) considered systemic at diagnosis, because potential hematogenous lymphogenic very high. efficacy intervention SCLC clear. Lung can performed using several techniques. Video-assisted thoracoscopic (VATS) safe, efficient, well accepted widespread technique among thoracic surgeons. 5-year survival rate following complete dependent. Incomplete rarely useful cures patient.